WESPAC Advisors SoCal LLC Buys Shares of 800 Humana Inc. (NYSE:HUM)

WESPAC Advisors SoCal LLC bought a new stake in Humana Inc. (NYSE:HUM) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 800 shares of the insurance provider’s stock, valued at approximately $347,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. raised its stake in shares of Humana by 5.8% during the 2nd quarter. BlackRock Inc. now owns 11,438,186 shares of the insurance provider’s stock valued at $4,435,158,000 after purchasing an additional 627,841 shares during the period. FMR LLC raised its stake in shares of Humana by 28.6% during the 2nd quarter. FMR LLC now owns 7,882,151 shares of the insurance provider’s stock valued at $3,056,304,000 after purchasing an additional 1,755,293 shares during the period. State Street Corp raised its stake in shares of Humana by 0.7% during the 1st quarter. State Street Corp now owns 5,819,500 shares of the insurance provider’s stock valued at $1,830,998,000 after purchasing an additional 39,441 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Humana by 13.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,446,353 shares of the insurance provider’s stock valued at $560,823,000 after purchasing an additional 167,297 shares during the period. Finally, Swiss National Bank raised its stake in shares of Humana by 0.6% during the 2nd quarter. Swiss National Bank now owns 610,912 shares of the insurance provider’s stock valued at $236,881,000 after purchasing an additional 3,700 shares during the period. Hedge funds and other institutional investors own 92.43% of the company’s stock.

HUM has been the subject of several recent analyst reports. Stephens boosted their target price on Humana from $433.00 to $450.00 and gave the stock an “overweight” rating in a research report on Monday, August 10th. Truist boosted their target price on Humana from $455.00 to $475.00 in a research report on Tuesday, October 13th. Piper Sandler boosted their target price on Humana from $473.00 to $495.00 and gave the stock an “overweight” rating in a research report on Thursday, October 1st. Mizuho boosted their target price on Humana from $420.00 to $462.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Finally, Royal Bank of Canada boosted their target price on Humana from $388.00 to $420.00 and gave the stock a “sector perform” rating in a research report on Monday, August 17th. Eight analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Humana has a consensus rating of “Buy” and a consensus target price of $437.43.

HUM stock traded down $9.12 during trading on Monday, hitting $435.19. 10,816 shares of the company traded hands, compared to its average volume of 1,047,044. The company has a 50-day moving average of $413.01 and a 200-day moving average of $394.43. The firm has a market capitalization of $58.78 billion, a PE ratio of 16.90, a P/E/G ratio of 1.85 and a beta of 0.88. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.69 and a current ratio of 1.69. Humana Inc. has a 1 year low of $208.25 and a 1 year high of $449.43.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $12.56 EPS for the quarter, beating analysts’ consensus estimates of $10.34 by $2.22. The business had revenue of $19.08 billion during the quarter, compared to analyst estimates of $18.66 billion. Humana had a return on equity of 26.70% and a net margin of 4.96%. Humana’s quarterly revenue was up 17.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.05 EPS. Sell-side analysts expect that Humana Inc. will post 19 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date is Tuesday, September 29th. Humana’s payout ratio is 13.99%.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also: What does the Producer Price Index (PPI) tell investors?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.